Brief: eFFECTOR Therapeutics Inc - Entered Into Controlled Equity Offering Sales Agreement With Cantor Fitzgerald & Co
Sept 1 (Reuters) - eFFECTOR Therapeutics Inc EFTR.O :
* EFFECTOR THERAPEUTICS INC - ENTERED INTO CONTROLLED EQUITY
OFFERING SALES AGREEMENT WITH CANTOR FITZGERALD & CO
* EFFECTOR THERAPEUTICS - UNDER AGREEMENT CO MAY, FROM TIME
TO
TIME, SELL SHARES OF CO’S COMMON STOCK HAVING OFFERING PRICE OF
UP TO $15.0 MILLION
Source text for Eikon: ID:
Further company coverage: EFTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright